Prostate News and Research

RSS

Study evaluates genetic predisposition in BPH patients developing prostate cancer

Patients with benign prostatic hyperplasia carrying prostate cancer a risk alleles are a potential target population for PCa screening and follow-up, according to a study, which was presented yesterday at the 28th Annual EAU Congress in Milan.

19 Mar 2013

Research reveals immortality gene mutation plays pivotal role in brain tumors, other cancers

Newly identified mutations in a gene that makes cells immortal appear to play a pivotal role in three of the most common types of brain tumors, as well as cancers of the liver, tongue and urinary tract, according to research led by Duke Cancer Institute.

19 Mar 2013

Digital rectal exam important for prostate screening, researchers say

The digital rectal exam is an important screening test that can discover prostate cancer that a prostate-specific antigen or PSA test may not, despite the higher sensitivity of the PSA test, according to Penn State College of Medicine researchers.

19 Mar 2013

Oral Cancer Foundation encourages dental practices to offer free oral cancer screenings in April

What has the greatest impact on survival rates of oral cancer? Radiation? Chemotherapy? Perhaps surgery? The truth is none of these; rather, it is the point in time at which the disease is discovered.

18 Mar 2013

Study examines risk of developing prostate cancer after last invitation to screening

Men who participate in biennial PSA based screening have a lower risk of being diagnosed as well as dying from prostate cancer up to 9 years after their last PSA test, according to the results of a new study to be presented at the 28th Annual EAU Congress in Milan.

18 Mar 2013

Abiraterone's anti-androgenic properties may stop tumor growth of CRPC, says prize-winning Dutch study

As part of an EU-supported IMI-PREDECT consortium, a Dutch study showed that anti-androgenic properties of the drug abiraterone may provide an additional mechanism of action in blocking tumour growth of castration resistant prostate cancer (CRPC).

16 Mar 2013

Study shows promising benefit of combination therapy in CRPC patients

Multi-peptide vaccination therapy combined with the low-dose steroid drug dexamethasone shows promise in treating chemotherapy-naive castration resistant prostate cancer (CRPC) patients.

16 Mar 2013

Surgery better than radiotherapy for treatment of localised prostate cancer

Surgery offers better survival benefit for men with localised prostate cancer, according to a large observational study, conducted by a group of researchers in Sweden and the Netherlands.

16 Mar 2013

Genetic score based on PCa risk-associated SNPs predicts prostate biopsy outcomes: Study

A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.

16 Mar 2013

Researchers identifiy elusive anti-cancer property of vitamin E

Researchers have identified an elusive anti-cancer property of vitamin E that has long been presumed to exist, but difficult to find. Many animal studies have suggested that vitamin E could prevent cancer, but human clinical trials following up on those findings have not shown the same benefits.

16 Mar 2013

Results from GTx's Phase 2 clinical trial of enobosarm published online

GTx, Inc. today announced that the journal, The Lancet Oncology, has published online ahead of its April print edition the results from GTx's randomized, double-blind, placebo-controlled Phase 2 clinical trial of enobosarm to assess its effects on muscle wasting and physical function in patients with cancer.

15 Mar 2013

Health law challenges leave some Democrats complaining -- in public, even

Some challenges associated with implementing the health law have some Democrats complaining about the law in public -- something once unthinkable.

13 Mar 2013

Study reveals impact of physician financial incentives and highlights importance of patient education

According to a new study by researchers at the Perelman School of Medicine at the University of Pennsylvania, prostate cancer patients of urologists who own expensive radiation equipment are more likely to receive radiation treatment in lieu of surgery than patients treated by urologists without an ownership stake in the equipment.

13 Mar 2013

Patients challenge hospital fees

The Boston Globe reports on this trend. In other news, CQ HealthBeat reports that the Medicare Payment Advisory Commission gave a nod to shared-decision making between doctors and patients.

12 Mar 2013

Researchers discover new mechanism that allows collective cell migration

Researchers at the University of Montreal's Institute for Research in Immunology and Cancer (IRIC) have discovered a new mechanism that allows some cells in our body to move together, in some ways like the tortoise formation used by Roman soldiers depicted in the Asterix series.

12 Mar 2013

DSMB recommends discontinuation of Aeterna Zentaris’ perifosine Phase 3 study for MM

Aeterna Zentaris Inc. today announced that an independent Data Safety Monitoring Board has recommended discontinuing the ongoing Phase 3 study comparing the efficacy and safety of perifosine to placebo when combined with bortezomib (Velcade) and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma.

12 Mar 2013

Prostate News and Research

Study evaluates genetic predisposition in BPH patients developing prostate cancer

Research reveals immortality gene mutation plays pivotal role in brain tumors, other cancers

Digital rectal exam important for prostate screening, researchers say

Oral Cancer Foundation encourages dental practices to offer free oral cancer screenings in April

Study examines risk of developing prostate cancer after last invitation to screening

Abiraterone's anti-androgenic properties may stop tumor growth of CRPC, says prize-winning Dutch study

Study shows promising benefit of combination therapy in CRPC patients

Surgery better than radiotherapy for treatment of localised prostate cancer

Genetic score based on PCa risk-associated SNPs predicts prostate biopsy outcomes: Study

Researchers identifiy elusive anti-cancer property of vitamin E

Results from GTx's Phase 2 clinical trial of enobosarm published online

Health law challenges leave some Democrats complaining -- in public, even

Study reveals impact of physician financial incentives and highlights importance of patient education

Patients challenge hospital fees

Researchers discover new mechanism that allows collective cell migration

DSMB recommends discontinuation of Aeterna Zentaris’ perifosine Phase 3 study for MM

Research: Stringent criteria for surveillance of prostate cancer needed for African Americans

SCCA, ProCure announce opening of Seattle Cancer Care Alliance Proton Therapy

Genomic analysis could illuminate more options in developing precise treatments for cancer

Lower back pain and spinal cancer: an interview with Dr Nicholas Henschke, University of Heidelberg

What to know about prostate cancer eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News